Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/EYWN stock hub

FRA/EYWN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/EYWNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.4B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/EYWN

In the news

Latest news · FRA/EYWN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.7

P25 n/aP50 n/aP75 n/a

Trailing P/E21.1

P25 n/aP50 n/aP75 n/a

ROE9.5

P25 n/aP50 n/aP75 n/a

ROIC13.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/EYWN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

228

Groups with data

Currency

EUR

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	DE
Employees	14,894
Employees Change	472%
Employees Change Percent	3.2
Enterprise value	EUR 8.3B
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	In Vitro and In Vivo Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 8.4B
Price	EUR 71.1
Price currency	EUR
Rev Per Employee	273,250.97x
Sic	2835
Symbol	fra/EYWN
Website	https://www.biomerieux.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.74%
EV Earnings	20.84x
EV/EBIT	11.92x
EV/EBITDA	7.09x
EV/FCF	18.28x
EV/Sales	2.04x
FCF yield	5.4%
Forward P/E	15.75x
P/B ratio	2.04x
P/E ratio	21.1x
P/S ratio	2.06x
PE Ratio10 Y	27.64x
PE Ratio3 Y	32.61x
PE Ratio5 Y	31.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.07%
EBITDA Margin	27.76%
FCF margin	11.13%
Gross margin	56.73%
Gross Profit	EUR 2.3B
Gross Profit Growth	-0.46%
Gross Profit Growth Q	-0.92%
Gross Profit Growth3 Y	2.87%
Gross Profit Growth5 Y	2.21%
Net Income	EUR 397.5M
Net Income Growth	-8.03%
Net Income Growth Q	9.04%
Net Income Growth3 Y	-1.13%
Net Income Growth5 Y	0.59%
Pretax Margin	12.92%
Profit Margin	9.77%
Profit Per Employee	EUR 26,689
ROA	7.66
Roa5y	8.29
ROCE	15.41
ROE	9.54
Roe5y	12.62
ROIC	13.12
Roic5y	14.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.3%
Cagr15y	8.03%
Cagr1y	-38.32%
Cagr3y	-9.19%
Cagr5y	-5.15%
Div CAGR10	11.39%
Div CAGR3	4.86%
Div CAGR5	9.59%
EPS Growth	-8.24
EPS Growth Q	9.36
EPS Growth3 Y	-1.26
EPS Growth5 Y	0.55
FCF Growth	40.93%
FCF Growth Q	4.99%
FCF Growth3 Y	42.56%
FCF Growth5 Y	21.35%
OCF Growth	18.15%
OCF Growth Q	0.15%
OCF Growth10 Y	3.07%
OCF Growth3 Y	16.81%
OCF Growth5 Y	10.81%
Revenue Growth	2.26x
Revenue Growth Q	-2.5x
Revenue Growth3 Y	2.25x
Revenue Growth5 Y	1.92x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.72
Assets	EUR 5.6B
Cash	EUR 569.8M
Current Assets	EUR 2.5B
Current Liabilities	EUR 1.1B
Debt	EUR 461.4M
Debt EBITDA	EUR 0.4
Debt Equity	EUR 0.11
Debt FCF	EUR 1.02
Equity	EUR 4.1B
Interest Coverage	43.97
Liabilities	EUR 1.5B
Long Term Assets	EUR 3B
Long Term Liabilities	EUR 404M
Net Cash	EUR 108.4M
Net Cash By Market Cap	EUR 1.29
Net Debt EBITDA	EUR -0.1
Net Debt Equity	EUR -0.03
Net Debt FCF	EUR -0.24
Tangible Book Value	EUR 3B
Tangible Book Value Per Share	EUR 25.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.39
Inventory Turnover	1.76
Net Working Capital	EUR 1B
Quick ratio	1.42
Working Capital	EUR 1.5B
Working Capital Turnover	EUR 2.86

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.06%
Dividend Growth	8.89%
Dividend Growth Years	1%
Dividend per share	EUR 0.98
Dividend Years	17
Dividend Yield	1.38%
Ex Div Date	2026-06-09
Last Dividend	EUR 0.98
Payout Frequency	Annual
Payout Ratio	26.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	102.21%
1Y total return	-38.3%
200-day SMA	105.1
3Y total return	-25.13%
50-day SMA	88.26
50-day SMA vs 200-day SMA	50under200
5Y total return	-23.25%
All Time High	144.7
All Time High Change	-50.86%
All Time High Date	2020-08-10
All Time Low	17.69
All Time Low Change	301.83%
All Time Low Date	2011-12-19
ATR	1.89
Ch YTD	-34.95
High	71.1
High52	130.6
High52 Date	2025-08-19
High52ch	-45.56%
Low	71.1
Low52	67.3
Low52 Date	2026-04-30
Low52ch	5.65%
Ma50ch	-19.44%
Price vs 200-day SMA	-32.36%
RSI	29.15
RSI Monthly	28.91
RSI Weekly	22.49
Sharpe ratio	-1.76x
Sortino ratio	-1.9
Total Return	1.32%
Tr YTD	-34.95
Tr15y	218.62%
Tr1m	-23.47%
Tr1w	-0.42%
Tr3m	-26.51%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 694.8M
Operating Income Growth	-1.28
Operating Income Growth Q	-2.57
Operating Income Growth3 Y	5.81
Operating Income Growth5 Y	4.34
Operating margin	17.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44,619,567%
Net Borrowing	-29,600,000
Shares Insiders	0.05%
Shares Institutions	17.51%
Shares Qo Q	-0.11%
Shares Yo Y	0.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 426.6M
Average Volume	408.9x
Bv Per Share	34.77
CAPEX	EUR -335.3M
Ch10y	89.28
Ch15y	179.9
Ch1m	-23.47
Ch1w	-0.42
Ch1y	-38.76
Ch3m	-26.51
Ch3y	-27.02
Ch5y	-26.35
Ch6m	-32.35
Change	-0.84%
Change From Open	0
Close	71.7
Days Gap	-0.84
Depreciation Amortization	434,900,000
Earnings Date	2026-07-28
EBIT	EUR 694.8M
EBITDA	EUR 1.1B
EPS	EUR 3.34
F Score	7
FCF	EUR 453.1M
FCF EV Yield	5.47x
Financing CF	-155,400,000
Fiscal Year End	December
Founded	1,963
Goodwill	727,800,000
Graham Number	51.37552
Graham Upside	-27.74
Income Tax	EUR 128.8M
Investing CF	-461,700,000
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Last Split Date	2017-09-20
Last Split Type	Forward
Lynch Fair Value	EUR 16.85
Lynch Upside	-76.3
Ma150	100.1
Ma150ch	-28.96%
Ma20	80.12
Ma20ch	-11.25%
Net CF	123,000,000
Next Earnings Date	2026-07-28
Open	71.1
P FCF Ratio	18.51
P OCF Ratio	10.64
Payment Date	2026-06-11
Ppne	1,657,200,000
Price Date	2026-05-08
Price EBITDA	EUR 7.42
Ptbv Ratio	2.82
Relative Volume	0.04x
Revenue	4,069,800,000x
SBC By Revenue	0.65x
Share Based Comp	26,500,000
Tax By Revenue	3.16x
Tax Rate	24.5%
Tr6m	-32.35%
Z Score	7.11

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/EYWN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.4%

$0.98 annual per share

Payout ratio

+26.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.6%

1 consecutive years of growth

Total shareholder yield

+1.3%

Next ex-dividend date: 2026-06-09

Performance

FRA/EYWN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/EYWN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.5%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

FRA/EYWN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

29.2

Below 30: short-term oversold

Price vs 200-day MA

-32.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/EYWN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/EYWN stock rating?

fra/EYWN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/EYWN analysis?

The full report lives at /stocks/fra/EYWN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/EYWN?

The latest report frames fra/EYWN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/EYWN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.